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TO THE EDITOR
Histological observations have shown
that unmyelinated nerve fibers origi-
nating from dorsal root ganglions are
present at higher densities in the
epidermis in several skin diseases
such as atopic dermatitis (AD), suggest-
ing that hyperinnervation is partly
responsible for abnormal itch percep-
tion (Steinhoff et al., 2003b; Ikoma
et al., 2006; Paus et al., 2006).
However, it has been difficult to histo-
logically identify itch-specific fibers
in the skin because there have been
no itch-specific markers available.
Recently, a study of gastrin-releasing
peptide receptor (GRPR)-deficient
mice has shown that the GRP/GRPR
system is specifically involved in
itch but not pain perception (Sun and
Chen, 2007). Therefore, this study was
conducted to immunohistochemically
identify and characterize cutaneous
nerve fibers containing GRP in NC/
Nga mice using an AD model (Matsuda
et al., 1997).
Male NC/Nga mice (SLC Japan,
Shizuoka, Japan) were maintained in
specific pathogen-free (SPF) or air-
uncontrolled conventional (Cnv) condi-
tions. We used Cnv-NC/Nga mice
of 8–12 weeks of age that manifested
mild to severe skin lesions similar to
AD, and SPF-NC/Nga mice with no AD
as a control. All animal procedures
were approved by the institutional
Animal Care and Use Committee at
Juntendo University Graduate School of
Medicine. The immunohistochemical
protocol for cutaneous nerve fibers
was performed as described previously
(Tominaga et al., 2007a). Cryosections
(thickness 20mm) from dorsal neck
skin were double-stained with anti-
GRP and anti-product gene protein
9.5 (PGP9.5). The sections were ob-
served with a confocal laser-scanning
microscope DMIRE2 (Leica, Wetzlar,
Germany).
In Cnv-NC/Nga mice, GRPþPGP9.5þ
fibers were observed in both the
epidermis (Figure 1a) and the dermis
(Figure 1b). They were mainly found in
the dermis of SPF-NC/Nga mice, espe-
cially at the dermoepidermal junction
(Figure 1c). Although the number of
nerve fibers was significantly high in
the epidermis and the dermis of
Cnv-NC/Nga mice compared with that
in SPF-NC/Nga mice (Figure 1d), the
percentage of GRPþ fibers in PGP9.5þ
fibers was approximately 2.4-fold
higher in the epidermis of Cnv-NC/
Nga mice, although this was not the
case in the dermis (Figure 1e).
To further examine whether GRPþ
fibers contain neuropeptides such as
substance P (SP) and calcitonin-gene-
related peptide (CGRP), which are
involved in neurogenic inflammation
and/or hypersensitivity of itch sensation
(Stander and Steinhoff, 2002; Steinhoff
et al., 2003b), skin samples of NC/Nga
mice were double-stained with antibo-
dies against GRP, SP, and CGRP. In the
epidermis and the dermis of Cnv-NC/
Nga mice, almost all GRPþ fibers
contained SP (Figure 1f) or CGRP
(Figure 1i), as did those in the dermis
of SPF-NC/Nga mice (Figure 1g and j).
Many CGRPþ fibers in the skin of
Cnv-NC/Nga (Supplementary Figure
S1a) and SPF-NC/Nga (Supplementary
Figure S1b) mice also contained SP. To
estimate the percentage of GRPþSPþ
or GRPþCGRPþ fibers in PGP9.5þ
fibers, the skin samples of NC/Nga mice
were triple-stained with antibodies
against GRP, PGP9.5, SP, and CGRP
(Figure 1h and k). In comparison
with SPF-NC/Nga mice, the percen-
tages of GRPþSPþ and GRPþCGRPþ
fibers in PGP9.5þ fibers were approxi-
mately 3.5-fold and 3.8-fold higher in
the epidermis of Cnv-NC/Nga mice,
respectively, although this was not
the case in the dermis. GRPSPþ or
GRPCGRPþ fibers were also observed
in the skin of these mice (Supplemen-
tary Table S1), but they remained as
uncharacterized nerve fibers in this
study.
The cutaneous GRPþ fibers in
Cnv-NC/Nga mice were immuno-
histochemically characterized using
antibodies against itch-related mole-
cules such as transient receptor
potential vanilloid 1 (TRPV1), pro-
tease-activated receptor 2 (PAR-2),
mu-opioid receptor (MOR), and tropo-
myosin-receptor-kinase A (Paus et al.,
2006). The GRPþ fibers expressed
TRPV1, but some GRPTRPV1þ fibers
were also observed in the atopic skin
(Figure 2a). The GRPþ fibers also
expressed PAR-2, MOR, or tropomyo-
sin-receptor-kinase A in the atopic skin
(Figure 2b–d).
In this study, we found that GRPþ
fibers were present in mouse skin, and
that the percentage of GRPþ fibers in
PGP9.5þ fibers was markedly high
only in the epidermis of atopic NC/
Nga mice. Small- to medium-sized
adult dorsal root ganglions neurons
express GRP, and its receptor is
present in the superficial dorsal horn.
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Abbreviations: AD, atopic dermatitis; CGRP, calcitonin-gene-related peptide; GRP, gastrin-releasing
peptide; MOR, mu-opioid receptor; PAR-2, protease-activated receptor 2; PGP9.5, product gene protein
9.5; SP, substance P; TRPV1, transient receptor potential vanilloid 1
Intrathecal injection of GRP18–27 into
wild-type mice induced scratching be-
havior, but did not affect pain sensiti-
vity (Sun and Chen, 2007). Therefore, it
is possible that GRPþ fibers are itch-
specific fibers in the skin. The increase
of epidermal GRPþ fiber density in
Cnv-NC/Nga mice is probably caused
by keratinocyte-derived nerve growth
factor (Tominaga et al., 2007a). This is
also supported by our data showing that
GRPþ fibers expressed tropomyosin-
receptor-kinase A, a receptor for nerve
growth factor. In addition, the GRPþ
fibers in the skin of NC/Nga mice
contained SP or CGRP, and the nerve
densities were significantly high in the
epidermis of Cnv-NC/Nga mice com-
pared with those in SPF-NC/Nga mice.
It is suggested that SP released from
sensory nerve fibers indirectly induce
pruritus via the activation of non-
neuronal skin cells expressing cognate
receptors (Paus et al., 2006). Although
the role of sensory nerve-derived CGRP
in the induction of pruritus remains
controversial, it has also been shown to
modulate itch sensation and inflamma-
tion (Bı´ro´ et al., 2007). Moreover, nerve
growth factor is known to upregulate
these neuropeptides in adult rat sensory
neurons (Verge et al., 1995). Therefore,
these findings raise the possibility that
GRPþ fibers modulate the neuronal/
non-neuronal interaction network to
initiate and augment itch. This is
strongly supported by our data showing
that GRP was localized in cutaneous
TRPV1þ fibers, which respond to
thermal and chemical stimuli (Bı´ro´
et al., 2007).
Our immunohistochemical data for
Cnv-NC/Nga mice showed that the
GRPþ fibers expressed PAR-2, which
is involved in histamine-independent
itch (Steinhoff et al., 2003a; Shimada
et al., 2006). Recent studies have
suggested a possible role of peripheral
opioid systems in pruritus (Inan and
Cowan, 2004; Bigliardi et al., 2007;
Tominaga et al., 2007b). We also
obtained noteworthy data showing
that GRP was localized in some MORþ
fibers of mouse skin. This may provide
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Figure 1. Immunohistochemical analyses of GRPþ fibers in the skin of NC/Nga mice. (a–c) Double-labeling of GRP (green) and PGP9.5 (red) in the skin of NC/Nga mice.
A small proportion of PGP9.5þ fibers expressed GRP in both the epidermis (arrows in a) and the dermis (b) of Cnv-NC/Nga mice. GRPþPGP9.5þ fibers were mainly
observed in the dermis of SPF-NC/Nga mice (arrows), but they were occasionally present in the epidermis (c). (d) The number of GRPþPGP9.5þ fibers was significantly
high in both the epidermis and the dermis of Cnv-NC/Nga mice compared with that in SPF-NC/Nga mice. *Po0.05. (e) The percentage of GRPþ fibers in PGP9.5þ fibers
was significantly high in the epidermis of Cnv-NC/Nga mice compared with that in SPF-NC/Nga mice, but was similar in the dermis of these mice. (f, g) Double-labeling of
GRP (green) and SP (red) in the skin of NC/Nga mice. Almost all GRPþ fibers contained SP in both the epidermis and the dermis of Cnv-NC/Nga mice (arrows in f). They
were mainly observed in the dermis of SPF-NC/Nga mice (arrows in g). (h) The percentage of GRPþSPþ fibers in PGP9.5þ fibers was significantly high in the epidermis of
Cnv-NC/Nga mice compared with that in SPF-NC/Nga mice, but was similar in the dermis of these mice. *Po0.05. (i, j) Double-labeling of GRP (green) and CGRP (red) in
the skin of NC/Nga mice. Many GRPþCGRPþ fibers (arrows) were observed in both the epidermis and the dermis of Cnv-NC/Nga mice (i). Some GRPCGRPþ fibers
were also found in the skin (an arrowhead in i). In SPF-NC/Nga mice, GRPþCGRPþ fibers (arrows) were mainly observed in the dermis (j). (k) The percentage of
GRPþCGRPþ fibers in PGP9.5þ fibers was significantly high only in the epidermis of Cnv-NC/Nga mice compared with that in SPF-NC/Nga mice. *Po0.05. In panels a,
b, c, f, g, i, and j, yellow areas are double-labeled, and white and broken lines indicate the skin surface and the border between epidermis (epi) and dermis (der),
respectively. Scale bars¼ 47.62mm (a, b, c, f, g, i, and j).
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Figure 1. Continued.
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Figure 2. Immunohistochemical expression of itch-related molecules in cutaneous GRPþ fibers of atopic NC/Nga mice. Double-labeling of GRP with
TRPV1 (a), PAR-2 (b), MOR (c), and TrkA (d) in the skin of NC/Nga atopic mice. (a) GRP (green) was localized in TRPV1þ (red) fibers in the skin (arrows).
Some GRPTRPV1þ fibers were also found in the skin (arrowheads). (b) GRPþ (green) fibers expressed PAR-2 (red) in the epidermis (arrows). (c) GRP (green)
was present in a small proportion of MORþ (red) fibers of the epidermis (inset) and the dermis. (d) GRP (green) was expressed in TrkAþ (red) fibers of the
epidermis (an arrow), and GRPTrkAþ fibers were also observed (arrowheads). Yellow areas in each panel are double-labeled. White and broken lines
indicate the skin surface and the border between epidermis (epi) and dermis (der), respectively. Scale bars¼ 23.81 mm.
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direct evidence for the involvement of
neuronal MOR in the induction and
modulation of peripheral itch. Although
we could not use immunohistochemical
analysis to confirm whether GRPþ fibers
express histamine receptors in this study
because of the lack of antihistamine-
receptor antibodies, the GRP/GRPR sys-
tem in the spinal cord is strongly related
to itch elicited by histamine-indepen-
dent mechanisms such as the PAR-2
agonist and chloroquine (Sun and Chen,
2007). Taken together, these findings
suggest the possibility that cutaneous
GRPþ fibers respond to other prurito-
gens rather than histamine.
The GRP/GRPR system has also been
documented to be expressed in normal
human skin cells such as nerves,
vessels, and keratinocytes, suggesting
that it is important for modulation of
various cell functions in the epidermis
(Staniek et al., 1996). Thus, future
studies will be necessary to examine
the expression of GRPR in the skin with
allergic inflammation such as AD.
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TO THE EDITOR
Primary cutaneous lymphomas are
characterized by the localization of
malignant lymphocytes to the skin at
presentation (Willemze et al., 2005). In
mycosis fungoides (MF), conventional
PCR of peripheral blood (PB) have
demonstrated the presence of mono-
clonal T cells in all stages, although less
often in early disease (Delfau-Larue
et al., 2000; Muche et al., 1997,
2003). MF is generally assumed to spare
bone marrow (BM) until advanced
stage, as evidenced by histopathology
(Sausville et al., 1988; Marti et al.,
1996); however, limited information is
available on molecular staging in BM
(Veelken et al., 1995; Sandberg et al.,
2003; Sibaud et al., 2003). The pre-
sence of malignant T cells in extracuta-
neous compartments in early-stage MF
is suggestive of a systemic nature
(Muche et al., 1997). If this is true, the
question arises whether it is possible to
detect minimal extracutaneous involve-
ment in patients diagnosed with local
disease by clinicopathology and con-
ventional clonality assays. To answer
this, 11 patients (two female, nine male,
average age: 64.9 years) with clinically
and histologically confirmed MF stage
IA–IIB were included in this study.
Extracutaneous samples were histologi-
cally uninvolved. Diagnosis of MF was
based on the EORTC (European Orga-
nization for Research and Treatment of
Cancer) classification for primary cuta-
neous lymphoma (Willemze et al.,
1997). BM biopsy was carried out for
routine staging of MF in all patients
regardless of the clinical stage of the
disease. DNA from skin, PB, and BM
was analyzed for the presence of TCRg
and TCRd rearrangements by manual
sequencing detection (Nyvold et al.,
2000). In addition, multiplex PCR of
cutaneous TCRb and TCRg gene re-
arrangements was performed according
to Biomedical and Health Research
Programme (BIOMED-2) guidelines
(van Dongen et al., 2003) and analyzed
with fluorescence fragment product
analysis on an automated capillary
electrophoresis DNA sequencer (Gen-
eScan; Applied Biosystems, Weiter-
stadt, Germany). PCR products were
purified and sequenced on an ABI
Prism 3100 Genetic Analyzer (Applied
Biosystems). Skin clonality in TCRg and
TCRb usage was detected in five and six
patients, respectively. On manual se-
quence analysis, two patients had
monoclonal patterns in BM. The BM
rearrangement (TCRd–V2D3) of patient
no. 4 was different from the cutaneous
rearrangements. One patient with a
polyclonal distribution in the skin had
identical clonal T cells in PB and BM
(Vg8–Jg1/2). These findings correlate
with reports of unrelated T-cell clones
in PB in up to 30% of patients with
MF, in benign lymphoproliferative
diseases, or occasionally in healthy
elderly donors (Delfau-Larue et al.,
2000; Beylot-Barry et al., 2001; Muche
et al., 2003).
Next, we wished to determine mini-
mal tumor infiltration using TCRg and
TCRb gene rearrangements identified in
the skin as clone-specific primers in
real-time quantitative PCR for the dis-
ease in PB and BM (Van der Velden
et al., 2003). Patient-specific PCR has
previously been used for molecular
diagnosis of cutaneous T-cell lympho-
mas (Lessin et al., 1991; Kono et al.,
1992; Veelken et al., 1995). The resolu-
tion power of conventional PCR tech-
niques is 1–5%, whereas clone-specific
real-time quantitative PCR enables the
detection of one malignant cell in up to
105 to 106 normal cells (van Dongen
et al., 2003). Six patients had suitable
clone-specific rearrangements in skin
samples. Primers covering as many
different genetic marker systems as
possible were designed for each patient
(Table 1). A modification of the guide-
lines for interpretation of real-time
quantitative PCR data in acute lympho-
blastic leukemia was used (van der
Velden et al., 2007). Results were
graded on a scale of 1–3 depending
on differences in the cycle threshold
value between the patients and poly-
clonal controls (Table 2). No patient
demonstrated a clear presence of neo-
plastic T cells in PB or BM (rating 1). An
indication of clonal cells (rating 2) was
achieved in three samples of PB and
BM, respectively. Only one patient had
rating 2 in both PB and BM. The rating
2 is comparable with criteria used in
studies in which false-negative results
must be prevented and positive results
due to non-specific amplification can-
not be excluded (van der Velden et al.,
2007). All patient specimens with rating
2 had only one of three replicates
positive and, with the exception of
one PB sample (patient no. 1), no
samples had rating 2 in more than one
of the applied genetic markers. Very
low levels of tumor infiltration make the
analysis less accurate and results shouldAbbreviations: BM, bone marrow; MF, mycosis fungoides; PB, peripheral blood
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